Metraipolis › archive › dc_fec16fc94240
Activation of TP53 target genes in the primary response of triple-negative breast cancer cells to doxorubicin treatment — Europe PMC PMID:41345520
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41345520
- DOI
- 10.1038/s41598-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T22:28:22.399Z
- SHA-256 of the archived text
6884dc4ee923a393c9ba7c6567eede85317aea326e6c3c453a0ea1d4495f181c- Stable URL of this page
https://metraipolis.com/documento/dc_fec16fc94240
How to cite
Activation of TP53 target genes in the primary response of triple-negative breast cancer cells to doxorubicin treatment — Europe PMC PMID:41345520 — Europe PMC (en), https://europepmc.org/article/MED/41345520 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fec16fc94240 (Metraipolis archive dc_fec16fc94240, sha256 6884dc4ee923a393c9ba7c6567eede85317aea326e6c3c453a0ea1d4495f181c)
BibTeX
@misc{dcfec16fc94240,
title = {Activation of TP53 target genes in the primary response of triple-negative breast cancer cells to doxorubicin treatment — Europe PMC PMID:41345520},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41345520},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fec16fc94240; sha256 6884dc4ee923a393c9ba7c6567eede85317aea326e6c3c453a0ea1d4495f181c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41345520. Agents can read the archived copy with the MCP tool read_document.